𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Alpha-synuclein in colonic submucosa in early untreated Parkinson's disease

✍ Scribed by Kathleen M. Shannon; Ali Keshavarzian; Ece Mutlu; Hemraj B. Dodiya; Delia Daian; Jean A. Jaglin; Jeffrey H. Kordower


Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
479 KB
Volume
27
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

The diagnosis of Parkinson's disease rests on motor signs of advanced central dopamine deficiency. There is an urgent need for disease biomarkers. Clinicopathological evidence suggests that α‐synuclein aggregation, the pathological signature of Parkinson's disease, can be detected in gastrointestinal tract neurons in Parkinson's disease. We studied whether we could demonstrate α‐synuclein pathology in specimens from unprepped flexible sigmoidoscopy of the distal sigmoid colon in early subjects with Parkinson's disease. We also looked for 3‐nitrotyrosine, a marker of oxidative stress. Ten subjects with early Parkinson's disease not treated with dopaminergic agents (7 men; median age, 58.5 years; median disease duration, 1.5 years) underwent unprepped flexible sigmoidoscopy with biopsy of the distal sigmoid colon. Immunohistochemistry studies for α‐synuclein and 3‐nitrotyrosine were performed on biopsy specimens and control specimens from a tissue repository (23 healthy subjects and 23 subjects with inflammatory bowel disease). Nine of 10 Parkinson's disease samples were adequate for study. All showed staining for α‐synuclein in nerve fibers in colonic submucosa. No control sample showed this pattern. A few showed light α‐synuclein staining in round cells. 3‐Nitrotyrosine staining was seen in 87% of Parkinson's disease cases but was not specific for Parkinson's disease. This study suggests a pattern of α‐synuclein staining in Parkinson's disease that was distinct from healthy subjects and those with inflammatory bowel disease. The absence of this pattern in subjects with inflammatory bowel disease suggests it is not a sequel of inflammation or oxidative stress. 3‐Nitrotyrosine immunostaining was common in all groups studied, suggesting oxidative stress in the colonic submucosa. © 2011 Movement Disorder Society.


📜 SIMILAR VOLUMES


Alpha-synuclein mRNA expression in spora
✍ Eng-King Tan; Van R. Chandran; Stephanie Fook-Chong; Hui Shen; Kenneth Yew; Mei- 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB 👁 1 views

## Abstract The expression of α‐synuclein gene can be influenced by the genomic load and/or epigenetic factors. By using quantitative real‐time polymerase chain reaction techniques, we demonstrated that the α‐synuclein gene mRNA expression in sporadic PD did not differ from healthy controls (median

Temporal lobe changes in early, untreate
✍ W.R. Wayne Martin; Marguerite Wieler; Myrlene Gee; Richard Camicioli 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 156 KB

## Abstract The purpose of this study was to determine if focal cortical abnormalities may occur in early Parkinson's disease (PD). We studied 26 untreated patients with early PD and 14 healthy control subjects, with cognitive screening and magnetic resonance imaging (MRI). Voxel‐based morphometry

Alpha-synuclein promoter haplotypes and
✍ E.V. De Marco; P. Tarantino; F.E. Rocca; G. Provenzano; D. Civitelli; V. De Luca 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB 👁 3 views

## Abstract Dementia is a common complication of Parkinson's disease (PD). It correlates significantly with the presence of cortical, limbic or nigral Lewy bodies, mainly constituted of alpha‐synuclein. Mutations of the alpha‐synuclein gene (SNCA) have been linked to rare familial forms of PD, whil

Clues to how alpha-synuclein damages neu
✍ David Sulzer 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

## Abstract Alpha‐synuclein (α‐syn) appears to normally regulate neurotransmitter release, possibly via calcium‐dependent binding and dissociation from lipid domains on secretory vesicles. The pathogenic effects of α‐syn leading to Parkinson's disease (PD) appear to result from alternate toxic effe